Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1567-1570

  Davidkin, Irja ^a   Valle, Martti ^b   Peltola, Heikki ^b   Hovi, Tapani ^b   Paunio, Mikko ^b   Roivainen, Merja ^b   Linnavuori, Kimmo ^b   Jokinen, Sari ^b   Leinikki, Pauli ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY TITER; ARTICLE; CHILD; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; FINLAND; FOLLOW UP; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; PREVALENCE; PRIORITY JOURNAL; RUBELLA; SERODIAGNOSIS; TREATMENT FAILURE; VIRUS DETECTION; VIRUS INFECTION;

ADENOVIRUSES, HUMAN; ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENTEROVIRUS; FINLAND; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; MEASLES; MEASLES VACCINE; MUMPS VACCINE; PARVOVIRUS; PROSPECTIVE STUDIES; RUBELLA; RUBELLA VACCINE;

EID: 0031764417     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314513     Document Type: Article

References (15)

1. Peltola H, Kurki T, Virtanen M, et al. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme. Lancet 1986;2:137-9.
2. Peltola H, Heinonen OP, Valle M, et al. Elimination of indigenous measles, mumps, and rubella from Finland by a twelve-year two-dose vaccination program. N Engl J Med 1994;331:1397-402.
3. Peltola H, Davidkin I, Valle M, et al. No measles in Finland. Lancet 1997;350:1364-5.
4. Brown DWG, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. Br Med J 1994;308:1015-7.
5. Shirley JA, Revill S, Cohen BJ, Buckley MM. Serological study of rubella-like illnesses. J Med Virol 1987;21:369-79.
6. Anderson MJ, Kidd IM, Morgan-Capner P. Human parvovirus and rubella-like illness. Lancet 1985;2:663.
7. Tait DR, Ward KN, Brown WG, Miller E. Exanthema subitum (roseola infantum) misdiagnosed in infants as measles or rubella. Br Med J 1996;312:101-2.
8. Frieden U, Resnick SD. Childhood exanthems, old and new. Pediatr Clin North Am 1991;38:859-87.
9. Waris M, Halonen P. Purification of adenovirus hexon protein by high-performance liquid chromatography. J Chromatogr 1987;397:321-5.
10. Roivainen M, Närvänen A, Korkolainen M, Huhtala ML, Hovi T. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology 1991;180:99-107.
11. Samuelsson A, Cello J, Skoog E, et al. Enterovirus IgG ELISA using synthetic peptides as antigens. Serodiagn Immunother Infect Dis 1993;5:93-6.
12. Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995;44:652-7.
13. Linnavuori K, Peltola H, Hovi T. Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum). Pediatrics 1992;89:103-6.
14. Davidkin I, Valle M. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps, and rubella vaccine. Twelve-year follow-up in two cohorts. Vaccine 1998;16:2052-7.
15. Vitek CR, Redd SC, Redd SB, Hadler SC. Trends in importation of measles to the United States, 1986-1994. JAMA 1997;277:1952-6.